What the results of Wegovy’s longest clinical trial yet show about ...
网页2024年5月13日 — New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
网页Today, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults...
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ for ...
网页2023年8月25日 — The study of 529 patients, funded by drugmaker Novo Nordisk, found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a...
Wegovy approved to lessen heart attack, stroke risk in overweight ...
网页2024年3月8日 — The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in...
FDA Approves New Drug Treatment for Chronic Weight …
网页FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
FDA approves Wegovy to reduce heart attack and stroke risk - NBC News
网页2024年3月8日 — The blockbuster weight loss drug Wegovy is now approved to reduce heart disease risk, drugmaker Novo Nordisk said Friday. The Food and Drug Administration has updated the drug's label, saying...
Wegovy Approved By FDA to Reduce Heart Attack Risk - The New York Times
网页2024年3月11日 — Wegovy, the blockbuster weight loss drug, is now approved for a new use: reducing the risk of heart attacks, strokes and cardiovascular-related death in adults who have heart disease and are...
Why weight-loss drug Wegovy shows promise for heart disease - NBC News
网页2023年11月11日 — The weight-loss drug Wegovy can reduce the risk of heart attacks and strokes by 20% in adults with heart disease and obesity, according to new research.
Wegovy shown to reduce risk of heart attack, stroke in major ...
网页2023年8月8日 — CNN — The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart-related death by 20% in what’s being called a landmark clinical trial in people with cardiovascular...
Novo Nordisk Wegovy approved for cutting heart disease risks
网页2024年3月8日 — The Food and Drug Administration on Friday approved Novo Nordisk ’s blockbuster weight loss drug Wegovy for use in slashing the risk of serious cardiovascular complications in adults with obesity...
- 某些结果已被删除